Previous Close | 23.99 |
Open | 24.06 |
Bid | 23.22 x 500 |
Ask | 23.29 x 1000 |
Day's Range | 23.20 - 24.06 |
52 Week Range | 13.82 - 25.95 |
Volume | |
Avg. Volume | 755,780 |
Market Cap | 2.106B |
Beta (5Y Monthly) | 1.97 |
PE Ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
On May 15, 2024, Paul Diaz, President and Chief Executive Officer of Myriad Genetics Inc (NASDAQ:MYGN), executed a significant transaction by selling 227,844 shares of the company.
On May 13, 2024, Director Lee Newcomer sold 6,200 shares of Myriad Genetics Inc (NASDAQ:MYGN) as reported in a recent SEC Filing.
As you might know, Myriad Genetics, Inc. ( NASDAQ:MYGN ) just kicked off its latest first-quarter results with some...